Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000950170-25-090197

Director acquired 1,070,663 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Manning Paul B Director 2025-06-25 Grant or award +1,070,663 $4.67 $4,999,996 2,213,069 I
Loading xslF345X05/ownership.xml…